Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysis

  • Berti, Alvise; 
  • Alsawas, Mouaz; 
  • Jawaid, Tabinda; 
  • Prokop, Larry J.; 
  • Lee, Jiwon M.; 
  • 외 8명
Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0

초록

Background Uncertainties exist about the use of mycophenolate mofetil (MMF) in anti-neutrophil cytoplasmatic antibody (ANCA)-associated vasculitis (AAV), particularly for remission maintenance. Methods Systematic review and meta-analysis of phase II and III trials assessing the use of MMF in AAV, granulomatosis with polyangiitis and microscopic polyangiitis (MPA). A comprehensive search of several databases (Medline, EMBASE, Cochrane, Web of Science, Scopus) from inception to 5 May 2020 has been conducted. Trial data were extracted to estimate odds ratios (ORs) and estimates (ES) for MMF efficacy (remission-induction and maintenance). Severe adverse effects (SAEs) were collected. Results From 565 articles captured, 10 met the predefined criteria, 5 phase II and 5 III trials; 4 assessed remission-induction, 3 remission maintenance and 3 both. The pooled OR for remission-induction at 6 months was 1.06 (95% confidence interval 0.74, 1.52), with no significant difference by subgroup meta-analysis of trials stratified by different study-level features (i.e. kidney disease, MPA, myeloperoxidase-ANCA positivity, newly diagnosed disease) (P > 0.05). The overall ES for remission maintenance at the end of follow-up ranged between 51% and 91% (I-2 = 74.8%). Subgroup meta-analysis identified kidney involvement as a possible source of heterogeneity, yielding a significantly higher rate of sustained remission in trials enrolling only patients with kidney involvement (92%, 76-100%) versus those enrolling patients with and without kidney involvement (56%, 45-66%). Results were similar in multiple sensitivity analyses. During follow-up, the frequency of SAEs in MMF-based treatment arms was 31.8%. Conclusions In AAV, MMF use was significantly associated with higher sustained remission rates in trials enrolling only patients with kidney involvement. These findings might influence clinical practice.

키워드

MMF; mycophenolate mofetil; ANCA-associated vasculitis; granulomatosis with polyangiitis; microscopic polyangiitis; ANTIBODY-ASSOCIATED VASCULITIS; CYCLOPHOSPHAMIDE; AZATHIOPRINE; RITUXIMAB; THERAPY; GLUCOCORTICOIDS
제목
Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysis
저자
Berti, Alvise; Alsawas, Mouaz; Jawaid, Tabinda; Prokop, Larry J.; Lee, Jiwon M.; Jeong, Gwang Hun; Quintana, Luis F.; Moiseev, Sergey; Vaglio, August; Tesar, Vladimir; Geetha, Duvuru; Shin, Jae Il; Kronbichler, Andreas
DOI
10.1093/ndt/gfab357
발행일
2022-10
유형
Review
저널명
Nephrology Dialysis Transplantation
권
37
호
11
페이지
2190 ~ 2200